Meijer CEO Praises Whitmer’s New Prescription Drug Law, Lowering Prescription Costs for Michiganders Rick Keyes, Meijer’s President and CEO says the new legislation, “makes pricing practices fairer, increases transparency, and helps our customers afford the medications they need to live healthy lives.”
By Main Street Sentinel Staff
Earlier this year, when Governor Whitmer passed three bills to significantly reduce prescription drug costs, Meijer President and CEO Rick Keyes announced his full support.
“Meijer cares about the communities we serve,” he said, and the Montcalm County-based company was, “proud to support this legislation.”
Keyes continued to say that the trio of bills, which was backed by Republican and Democrat legislators alike, makes “pricing practices fairer, increases transparency, and helps our customers afford the medications they need to live healthy lives.”
The new laws will rein in the costs tacked on by licensing pharmacy benefits managers – middlemen who control whether patients can access their prescriptions and how much they pay.
Upon signing the bills, Governor Gretchen Whitmer said that, “for too long, unlicensed pharmacy benefit managers have been able to engage in practices that drive up costs for Michiganders whose lives and health depend on critical prescription drugs like insulin.”
Plans to address runaway insulin prices are moving forward in the legislature, with Governor Whitmer and a group of Democratic and Republican lawmakers working together to pass a bill that will cap patients’ monthly insulin expenditures at $50.